pre-pectoral IBBR
ProcedureThe breast is reconstructed by positioning a breast implant above (pre-pectoral) the pectoralis major muscle.
NCT Number: NCT04293146
This trial is to investigate whether pre-pectoral Implant-Based Breast Reconstruction (IBBR) provides better Quality of Life (QoL) with respect to long-term (24 months) physical well-being (chest) compared to sub-pectoral IBBR for patients undergoing skin-sparing mastectomy or nipple-sparing mastectomy for prevention or treatment of breast cancer.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
Female
Interventional
Not applicable
Universitätsklinik für Frauenheilkunde und Geburtshilfe, Salzburg, Austria
This trial is to investigate whether pre-pectoral Implant-Based Breast Reconstruction (IBBR) provides better Quality of Life (QoL) with respect to long-term (24 months) physical well-being (chest) compared to sub-pectoral IBBR for patients undergoing skin-sparing mastectomy or nipple-sparing mastectomy for prevention or treatment of breast cancer.The aim is to adhere to standard of care as much as possible to follow the pragmatic trial design to generate data that are applicable to today's practice. Therefore, surgeons are allowed to use their preferred Acellular Dermal Matrix (ADM), synthetic meshes, expanders and implants, thereby offering practitioners considerable leeway in deciding how to perform the procedure. For the same reason, both the one- and two-staged IBBR approaches are allowed when studying pre- versus sub-pectoral IBBR.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The breast is reconstructed by positioning a breast implant above (pre-pectoral) the pectoralis major muscle.
The breast is reconstructed by positioning a breast implant below (sub-pectoral) the pectoralis major muscle.
Time frame: within 24 months after mastectomy (screening, day 10, and months 1, 6, 12 and 24)
compare the Quality of Life (QoL) with respect to long-term physical well-being (chest) after pre-pectoral or sub-pectoral IBBR. The BREAST-Q module specific to breast reconstruction version 2.0 consists of 13 independent scales covering health-related QoL domains and satisfaction domains. Each scale is scored to generate a numerical score on a scale from 0 (worst) to 100 (best).
Time frame: within 24 months after mastectomy (screening, day 10, and months 1, 6, 12 and 24)
The 5-level version of the EQ-5D (EQ-5D-5L) consists of the EQ-5D descriptive system that comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/Depression (5 answer levels each: no problems, slight problems, moderate problems, severe problems and extreme problems), resulting in a 1-digit number that expresses the level for that dimension. The digits for each dimension are combined into a 5-digit number that describes the patient's health state and is subsequently converted into a preference-based quality of life weight (utility) using an algorithm derived from population-based studies. In addition, patients are asked to rate their health on a vertical visual analogue scale (EQ VAS), where the anchors are labelled with 'The best health you can imagine' and 'The worst health you can imagine'.
Time frame: within 24 months of undergoing mastectomy and immediate reconstruction
compare the safety of pre-pectoral and sub-pectoral IBBR, in terms of loss of expander or implant. Loss of expander or implant is defined as an unplanned surgical removal of expander/implant with or without immediate replacement.
Time frame: within 24 months of undergoing mastectomy and immediate reconstruction
compare the safety of pre-pectoral and sub-pectoral IBBR, in terms of surgical complications. The complications include: Wound dehiscence, Haematoma, Seroma, Implant/expander exposure/Extrusion, Implant/Expander rotation/malpositioning, Infection, Mastectomy skin flap necrosis, Capsular contraction, Lymphedema
Time frame: within 24 months of undergoing mastectomy and immediate reconstruction
compare the safety of pre-pectoral and sub-pectoral IBBR, in terms of thromboembolic events according to Common Terminology Criteria for Adverse Events (CTCAE) v5.0
Time frame: over 24 months since mastectomy
compare patient satisfaction after pre-pectoral or sub-pectoral IBBR
Time frame: before and 24 months after the mastectomy
compare animation deformity after pre-pectoral or sub-pectoral IBBR by using pictures from before and 24 months after the mastectomy
Time frame: before and 24 months after the mastectomy
compare capsular contracture after pre-pectoral or sub-pectoral IBBR by using pictures from before and 24 months after the mastectomy
Time frame: before and 24 months after the mastectomy
compare aesthetic results after pre-pectoral or sub-pectoral IBBR assessed by photographs of the breast taken in a standardized way. They will be evaluated by an experienced investigator who is blinded for group assignment. The blinded outcome assessment team will be trained to enter data for the two most widely used semi-automatic software for objective aesthetic evaluation, the 'Breast Cancer Conservative Treatment cosmetic results' (BCCT.core)
Time frame: until 10 years after mastectomy and IBBR.
RFS is defined as the time from randomization until the first documentation of any of the following events: local-regional occurrence or recurrence of invasive disease or ductal carcinoma in situ (DCIS), distant breast cancer metastasis, or death from any cause.
Time frame: at baseline and after 24 months
evaluated by patients using a four point scale: excellent, good, regular, bad.
Time frame: until 24 months after mastectomy
assess the burden on patients by total number of operative procedures
Time frame: until 24 months after randomization
length of hospital stay (index hospitalization and overall) following randomization until discharge and the cumulative number of days the patient was hospitalized
Time frame: from admission for mastectomy until 24 months after randomization
assess the burden on patients by total number of outpatient visits at the trial site and the emergency department
Time frame: at baseline and after 24 months
evaluated by local physicians using a four point scale: excellent, good, regular, bad.
University Hospital, Basel, Switzerland
Other
Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy (OPBC-02/ PREPEC): a Pragmatic, Multicenter, Randomized, Superiority Trial
Acronym: OPBC-02PREPEC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02724371
Breast Reconstruction, Revision Breast Reconstruction
Montgomery, Alabama, United States
View Trial DetailsNCT05377723
Breast Reconstruction, Cicatrix
Stanford, California, United States
View Trial DetailsNCT06555692
Breast Cancer Female, Breast Reconstruction
Seoul, South Korea
View Trial DetailsNCT06627582
Breast Reconstruction, Breast Reconstruction After Mastectomy
Basking Ridge, New Jersey, United States
View Trial Details